Internal Medicine, Nephrology · Houston, TX
NPI
1881696888
Since 2005
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1415 la Concha Ln
Houston, TX, 77054
Phone (713) 790-9080
Groups this clinician bills Medicare through
Medicare paid, 2024
$221K
2,461 services
Medicare patients, 2024
460
Average age 74
Drug cost, 2024
$3.1M
2,705 prescriptions
Company payments, 2025
$2,474
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Binh T Nguyen was code 99232 (hospital e&m - subsequent), 1,115 times for 273 patients. In total Binh T Nguyen billed 2,461 services in 22 codes, and Medicare paid $221K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-10-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,115 | 273 | $65.05 | $73K |
| 99214 Office E&M - Established | Office | 308 | 125 | $92.36 | $28K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 213 | 111 | $12.23 | $2,606 |
| 90960 ESRD Related Services (not dialysis) | Office | 170 | 38 | $294.00 | $50K |
| 99222 Hospital E&M - Initial | Facility | 127 | 91 | $105.70 | $13K |
| 99223 Hospital E&M - Initial | Facility | 80 | 80 | $135.75 | $11K |
| 90961 ESRD Related Services (not dialysis) | Office | 71 | 30 | $247.99 | $18K |
| 99233 Hospital E&M - Subsequent | Facility | 46 | 20 | $97.20 | $4,471 |
| 90935 Hemodialysis | Facility | 38 | 26 | $56.97 | $2,165 |
| 99204 Office E&M - New | Office | 21 | 21 | $135.22 | $2,840 |
| 90962 ESRD Related Services (not dialysis) | Office | 21 | 13 | $163.07 | $3,424 |
| 99213 Office E&M - Established | Office | 20 | 15 | $52.16 | $1,043 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 14 | 13 | $175.22 | $2,453 |
By year: 2022 $243K for 2,433 services; 2023 $265K for 2,734 services; 2024 $221K for 2,461 services.
Medicare prescription drug claims, 2024
In 2024, the drug Binh T Nguyen prescribed most often to Medicare patients was Vascepa (Icosapent Ethyl), with 296 prescriptions and refills. In total Binh T Nguyen wrote 2,705 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vascepa Icosapent Ethyl | 296 | 585 | 88 | $206K |
| Jardiance Empagliflozin | 266 | 613 | 86 | $356K |
| Rayaldee Calcifediol | 221 | 249 | 49 | $288K |
| Farxiga Dapagliflozin Propanediol | 186 | 414 | 57 | $228K |
| Allopurinol Generic | 152 | 434 | 57 | $1,257 |
| Procrit Epoetin Alfa | 105 | 127 | 19 | $97K |
| Paricalcitol Generic | 101 | 286 | 37 | $15K |
| Kerendia Finerenone | 92 | 227 | 41 | $144K |
| Sevelamer Carbonate Generic | 79 | 157 | 31 | $18K |
| Icosapent Ethyl Generic | 73 | 150 | 35 | $23K |
| Lokelma Sodium Zirconium Cyclosilicate | 66 | 122 | 22 | $62K |
| Furosemide Generic | 66 | 159 | 24 | $345 |
| Losartan Potassium Generic | 61 | 169 | 24 | $448 |
| Velphoro Sucroferric Oxyhydroxide | 60 | 64 | 16 | $135K |
| Nifedipine Er Nifedipine | 55 | 150 | 28 | $1,711 |
Brand drugs: 1,435 claims; generic drugs: 1,270 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Binh T Nguyen $2,474 ($2,474 in general payments such as food, travel and fees) from 21 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $430.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 7 | $430 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $254 |
| OPKO Pharmaceuticals, LLC | 22 | $237 |
| Ardelyx, Inc. ARDX | 10 | $217 |
| Novartis Pharmaceuticals Corporation NVS | 10 | $215 |
| Travere Therapeutics, Inc. TVTX | 9 | $208 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 12 | $196 |
| Calliditas Therapeutics US Inc. | 7 | $190 |
| Mallinckrodt Hospital Products Inc. | 6 | $142 |
| Apellis Pharmaceuticals, Inc. APLS | 2 | $67.66 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.